ENCLONY pushes global expansion with tablet inspection tech
ENCLONY is expanding its pharmaceutical inspection business across North America, Europe and Japan with automated tablet and capsule vision systems and integrated laser printing. The Seoul-based company is targeting higher-throughput manufacturing lines as it broadens support through local subsidiaries and global trade shows.
Why it matters: - Pharmaceutical manufacturers are under pressure to improve quality control without slowing production. - ENCLONY's systems are built to inspect tablets and capsules at high speed while detecting defects, foreign matter and print errors. - The company's push into more markets could widen access to automated inspection tools for global drugmakers.
What happened: - ENCLONY said it is accelerating global expansion from its base in Seoul, South Korea. - The company develops machine vision equipment that automatically inspects tablet and capsule appearance during pharmaceutical production. - ENCLONY's flagship PLANET EV series analyzes fast-moving tablets and capsules from multiple angles. - The system detects foreign matter, breakage, discoloration, printing flaws and surface defects. - ENCLONY is also selling integrated automation that combines laser printing and vision inspection in one process. - The company marks product identification directly on tablet surfaces and inspects both the print and the tablet appearance in the same workflow. - ENCLONY said it has supplied equipment to Pfizer, Johnson & Johnson, AbbVie, Viatris and Eisai. - The company is strengthening sales and technical support in Japan through Nippon ENCLONY and its Osaka showroom. - ENCLONY GmbH is helping expand the company's reach across Europe.
The details: - ENCLONY was founded in 2013. - The high-speed inspection platform is engineered to inspect up to 425,000 tablets per hour. - The company is focusing on flexibility across product types, ease of use and integration with existing production lines. - ENCLONY showed its tablet and capsule inspection systems, along with laser printing-inspection solutions, at interpack 2026 in Düsseldorf, Germany. - The company is seeking more exposure with international pharmaceutical and packaging exhibitions. - The full company announcement is available here.
Between the lines: - ENCLONY is positioning automation as a way to solve two manufacturing problems at once: throughput and quality control. - The combination of local subsidiaries and trade-show visibility suggests a market-entry strategy built around direct support and relationship selling. - A 425,000-tablets-per-hour system signals a focus on large-scale production lines rather than niche applications.
What's next: - ENCLONY said it will reinforce customer support in Europe and Japan. - The company plans to keep expanding its presence in global pharmaceutical markets. - Continued product development will likely center on inspection flexibility, automation and line integration.
The bottom line: - ENCLONY is using high-speed inspection and integrated laser printing to compete for more global drug manufacturing business.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Health Daily South Korea
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.